Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-01-04 @ 3:36 PM
Study NCT ID:
NCT03812393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-18
First Post:
2019-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
Sponsor:
West Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-08
First Submit QC Date:
None
Study First Post Date:
2019-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-15
Last Update Post Date:
2023-12-18
Last Update Post Date Type:
ACTUAL